Top 10 Companies in the (S)-3-Methylpiperidine (CAS 17305-22-5) Market (2026): Market Leaders Powering Global Pharmaceutical Synthesis

MARKET INSIGHTS

The Global (S)-3-Methylpiperidine (CAS 17305-22-5) market size was valued at USD 28.4 million in 2025. The market is forecast to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.5% during the forecast period.

(S)-3-Methylpiperidine (CAS 17305-22-5) is a chiral six‑membered nitrogen‑containing heterocyclic compound, characterized by a methyl substituent at the 3‑position in the (S)-enantiomeric configuration. It serves as a key building block and intermediate in pharmaceutical synthesis, particularly in the development of active pharmaceutical ingredients (APIs), agrochemicals, and specialty fine chemicals. Its well‑defined stereochemistry makes it especially valuable in asymmetric synthesis applications where enantiopurity is critical.

The market is witnessing steady growth driven by rising demand for chiral intermediates in drug discovery and development, coupled with the expanding global pharmaceutical pipeline. Furthermore, increasing investments in contract research and manufacturing organizations (CROs and CMOs) are reinforcing demand for high‑purity enantiomeric building blocks such as (S)-3‑Methylpiperidine. Key suppliers operating in this space include Combi‑Blocks, Sigma‑Aldrich (Merck KGaA), TCI Chemicals, and AK Scientific, among others.

(S)-3-Methylpiperidine (CAS 17305-22-5) Market – View in Detailed Research Report

🔟 1. Combi‑Blocks Inc.

Headquarters: Irvine, California, USA
Key Offering: High‑purity chiral amines and building blocks for pharmaceutical synthesis

Combi‑Blocks has built a reputation for delivering enantiomerically pure intermediates with rapid turnaround times. Their advanced asymmetric hydrogenation platforms enable scalable production of (S)-3‑Methylpiperidine, meeting the stringent purity requirements of API development.

Sustainability Initiatives:

• Investment in greener catalytic processes to reduce solvent use
• Collaboration with CDMOs to integrate waste‑minimization protocols
• Commitment to ISO 14001 environmental management standards

9️⃣ 2. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: Comprehensive catalog of chiral building blocks for research and industrial applications

Sigma‑Aldrich supplies a broad range of (S)-3‑Methylpiperidine with detailed analytical data, facilitating rapid integration into drug discovery pipelines. Their global distribution network ensures consistent supply for both academic and commercial users.

Sustainability Initiatives:

• Use of bio‑derived solvents in synthesis routes
• Carbon‑neutral production targets by 2030
• Transparent reporting of impurity profiles to support regulatory compliance

8️⃣ 3. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: Custom synthesis of chiral amines with precision enantiomeric excess

TCI’s asymmetric hydrogenation expertise allows for tailored production of (S)-3‑Methylpiperidine, delivering high‑quality material for both early‑stage research and large‑scale manufacturing.

Sustainability Initiatives:

• Development of recyclable chiral catalysts
• Reduction of hazardous waste through process optimization
• Engagement in circular economy initiatives for chemical feedstocks

7️⃣ 4. AK Scientific

Headquarters: Charlotte, North Carolina, USA
Key Offering: Advanced chiral amine solutions for pharmaceutical and agrochemical sectors

AK Scientific focuses on delivering GMP‑grade (S)-3‑Methylpiperidine with robust analytical support, enabling seamless integration into downstream API synthesis.

Sustainability Initiatives:

• Implementation of energy‑efficient reactor designs
• Partnerships with CDMOs to reduce overall carbon footprint
• Commitment to zero‑waste production processes

6️⃣ 5. Hubei Norna Technology Co., Ltd.

Headquarters: Wuhan, China
Key Offering: Bulk and research‑grade chiral intermediates for API manufacturing

Hubei Norna Technology leverages large‑scale asymmetric hydrogenation infrastructure to supply high‑purity (S)-3‑Methylpiperidine to global pharmaceutical clients, emphasizing process consistency and rapid scale‑up.

Sustainability Initiatives:

• Adoption of renewable energy sources for production facilities
• Optimization of catalyst recovery to minimize resource consumption
• Compliance with local and international environmental regulations

5️⃣ 6. ABCR GmbH

Headquarters: Munich, Germany
Key Offering: Custom synthesis of chiral building blocks for pharmaceutical R&D

ABCR provides tailored (S)-3‑Methylpiperidine solutions, supporting complex synthetic routes with precise enantiomeric control and comprehensive analytical documentation.

Sustainability Initiatives:

• Investment in green chemistry laboratories
• Reduction of solvent consumption through process intensification
• Transparent supply chain traceability for raw materials

4️⃣ 7. Capot Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Research‑grade chiral amines for academic and industrial laboratories

Capot Chemical delivers high‑purity (S)-3‑Methylpiperidine with extensive quality data, enabling rapid screening and SAR studies in drug discovery projects.

Sustainability Initiatives:

• Implementation of waste‑water treatment systems
• Use of biodegradable packaging for laboratory supplies
• Participation in local environmental stewardship programs

3️⃣ 8. Accela ChemBio Inc.

Headquarters: Shenzhen, China
Key Offering: High‑purity chiral intermediates for API development and agrochemical synthesis

Accela ChemBio focuses on scalable production of (S)-3‑Methylpiperidine, providing detailed purity reports and supporting documentation for regulatory submissions.

Sustainability Initiatives:

• Adoption of energy‑efficient catalytic processes
• Collaboration with CDMOs to reduce overall environmental impact
• Continuous improvement of raw‑material sourcing to lower carbon intensity

2️⃣ 9. Enamine Ltd.

Headquarters: Kyiv, Ukraine
Key Offering: Screening libraries and chiral building blocks for medicinal chemistry

Enamine supplies (S)-3‑Methylpiperidine as part of its extensive library of chiral compounds, facilitating rapid hit‑to‑lead conversion in pharmaceutical research.

Sustainability Initiatives:

• Implementation of green synthesis protocols for library compounds
• Partnerships with academic institutions to promote sustainable research practices
• Transparent reporting of environmental metrics for supply chain partners

1️⃣ 10. Oakwood Chemical

Headquarters: Irvine, California, USA
Key Offering: High‑purity chiral intermediates for API synthesis and specialty chemicals

Oakwood Chemical delivers (S)-3‑Methylpiperidine with stringent quality control, supporting large‑scale manufacturing and research‑grade applications alike.

Sustainability Initiatives:

• Use of renewable energy in manufacturing facilities
• Investment in waste‑reduction technologies for chiral synthesis
• Commitment to ISO 14001 environmental management

---

Download FREE Sample Report: (S)-3-Methylpiperidine (CAS 17305-22-5) Market – View in Detailed Research Report

Get Full Report: (S)-3-Methylpiperidine (CAS 17305-22-5) Market – View in Detailed Research Report

---

📈 Market Outlook

The forecast period is marked by a steady expansion in the demand for chiral intermediates, driven by the growing pipeline of small‑molecule therapeutics and the increasing reliance on CDMOs for early‑stage synthesis. The market is expected to reach USD 52.7 million by 2034, reflecting a balanced mix of established API production and emerging research‑grade consumption.

🌍 Future Trends

• Continued adoption of biocatalytic routes for (S)-3‑Methylpiperidine production, offering lower waste and reduced energy consumption.
• Expansion of digital manufacturing platforms that enable rapid scale‑up and real‑time quality monitoring.
• Greater emphasis on regulatory transparency, with suppliers providing full impurity profiles and chiral purity data to support global submissions.
• Increased focus on sustainability, prompting the development of recyclable chiral catalysts and greener solvent systems.
• Growth in agrochemical applications, where chiral piperidine derivatives are used in single‑enantiomer pesticides and herbicides.